Zacks Small Cap Research on MSN

CVKD: Results show 12-LOX inhibition targets inflammation from obesity and type 2 diabetes

By David Bautz, PhD NASDAQ: CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Published Results Show Potential for ...
Labroots

Heparin Resistance in Critically Ill Patients: Best Practices Using Laboratory Coagulation Assays

Hospitalized patients with various underlying illnesses are routinely given parenterally administered unfractionated heparin (UFH) in order to prevent and/or treat thromboembolic events. In some cases ...